Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORAL-28Generic

OVRAL-28

ETHINYL ESTRADIOL; NORGESTREL

Standard Dose
0.05MG;0.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview OVRAL-28 is listed in Drugs@FDA under application 016806 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; NORGESTREL Form and strength TABLET;ORAL-28 - 0.05MG;0.5MG Sponsor WYETH PHARMS Submission history Latest submission status date: 2002-03-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview OVRAL-28 is listed in Drugs@FDA under application 016806 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; NORGESTREL Form and strength TABLET;ORAL-28 - 0.05MG;0.5MG Sponsor WYETH PHARMS Submission history Latest submission status date: 2002-03-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.